News & Analysis on Clinical Trial Services & Contract Research And Development
Becton Dickinson (BD) has extended its existing franchise in safety injection products and insulin delivery technologies into the safety pen needle market, with the US launch of the BD AutoShield Pen Needle.
Indian contract research organisation (CRO) Synchron has acquired local start-up CRO Innovance - a first-of-its-kind buyout in this booming area of the pharma market.
INC Research has become the latest contract research organisation (CRO) to dive into India, whilst Pharmaceutical Products Development (PPD) has opened offices in Athens and Seattle.
AAIPharma yesterday announced that it has completed a major round of upgrades to two of its manufacturing plants in the US.
A new range of software has been launched to provide researchers with tools to analyse multiple proteomics techniques and yield more complete data sets.
US-based Ajinomoto Aminoscience has launched AminoStable, an L-Alanyl-L-Glutamine dipeptide for use in pharmaceutical products and cell culture media.
Contract logistics provider Kuehne + Nagel (K+N) has announced it is expanding its capacity in Dubai in a bid to provide a global hub for pharmaceutical companies.
German contract manufacturer Vetter Pharma-Fertigung has been bestowed with a "facility of the year award" for the processes employed at its new injectables plant.
Pfizer has homed in pSivida's controlled release drug delivery technology, signing a research and licensing deal worth $165m (€123.5m) and focusing keenly on the company's Medidur technology for new ophthalmic applications.
First its lead product failed a Phase III clinical trial, and now a different anticancer drug has produced 'lacklustre' results, leaving Neopharm with an uncertain future, according to some industry analysts.
Japan is getting serious about clinical trial reform after years of lagging behind the rest of the developed world in the availability of drugs in the country, which ironically is the world's number two pharma market behind the US.